Short description:
Motion-based Drug Design
Drug notes:
RLY-4008 Clin1 multiple cancers; RLY-2608 Clin1 multiple cancers; 3 programs Clin0 oncology, undisclosed
Long description:
Relay Therapeutics is identifying drugs to alter protein kinetics to treat patients with cancer and genetic diseases. Proteins are not stationary - they move, and how they move can inform function and disease. Using their Dynamo platform, Relay is visualizing protein motions in HD movies and pioneering Motion-based Drug Design. The platform combines both deep structural understanding and chemical biology insights with AI and physics-based simulations to harness protein dynamics. With this, Relay can then develop unique hypotheses for how best to modulate a protein’s behavior and identify potential novel allosteric binding sites for therapeutics. Relay’s pipeline includes several promising product candidates in early and preclinical stages.
Jobs:
Associate Director, Medical Writing Cambridge, MA|8 days ago
Senior Manager, Clinical Supply Chain Cambridge, MA|8 days ago
Senior Manager / Associate Director, Clinical Scie... Cambridge, MA|14 days ago
Senior Scientist, Medicinal Chemistry Cambridge, MA|21 days ago
Associate Director, Technical Accounting Cambridge, MA|24 days ago
Scientist, Biology Cambridge, MA|45 days ago
Senior / Principal Scientist, DMPK Cambridge, MA|49 days ago
Director, Translational Medicine Cambridge, MA|49 days ago
Director, Bioinformatics Cambridge, MA|100+ days ago